基金经理：宋钊贤
| 单位净值:1.7920 | 净值增长率:-0.06% | 净值增长率:-0.06% | 累计净值:1.7920 | 截止日期:2026/5/11 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:0.34亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
易方达标普生物科技指数(QDII-LOF)C(人民币份额)(012866)资产配置 |
|||||
|---|---|---|---|---|---|
| 报告日期 | 股票(元) | 债券(元) | 基金总资产(元) | 基金净值(元) | 股票占净值比 |
| 2026/3/31 | 343,715,000 | - | 367,146,000 | 361,394,000 | 95% |
| 2025/12/31 | 504,397,000 | - | 543,733,000 | 540,571,000 | 93% |
| 2025/9/30 | 421,608,000 | - | 449,588,000 | 444,884,000 | 95% |
| 2025/6/30 | 315,033,000 | - | 335,093,000 | 333,553,000 | 94% |
| 2025/3/31 | 279,832,000 | - | 303,486,000 | 296,811,000 | 94% |
| 2024/12/31 | 285,128,000 | - | 306,733,000 | 305,975,000 | 93% |
| 2024/9/30 | 300,927,000 | - | 319,170,000 | 317,588,000 | 95% |
| 2024/6/30 | 297,835,000 | - | 317,397,000 | 316,716,000 | 94% |
| 2024/3/31 | 303,428,000 | - | 327,932,000 | 327,020,000 | 93% |
| 2023/12/31 | 296,753,000 | - | 317,815,000 | 316,138,000 | 94% |
| 2023/9/30 | 253,084,000 | - | 269,835,000 | 268,931,000 | 94% |
| 2023/6/30 | 292,636,000 | - | 319,369,000 | 315,750,000 | 93% |
| 2023/3/31 | 272,069,000 | - | 289,526,000 | 288,638,000 | 94% |
| 2022/12/31 | 305,254,000 | - | 325,145,000 | 324,169,000 | 94% |
| 2022/9/30 | 306,717,000 | - | 326,981,000 | 325,425,000 | 94% |
| 2022/6/30 | 280,999,000 | - | 304,693,000 | 301,125,000 | 93% |
| 2022/3/31 | 198,278,000 | - | 213,445,000 | 210,931,000 | 94% |
| 2021/12/31 | 142,445,000 | - | 154,563,000 | 151,476,000 | 94% |
| 2021/9/30 | 147,325,000 | - | 159,285,000 | 155,774,000 | 95% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。